| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | disaccharide binding | 5.32e-08 | 7 | 24 | 3 | GO:0048030 | |
| GeneOntologyMolecularFunction | galactoside binding | 1.28e-07 | 9 | 24 | 3 | GO:0016936 | |
| GeneOntologyMolecularFunction | oligosaccharide binding | 1.72e-06 | 20 | 24 | 3 | GO:0070492 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 1.09e-04 | 78 | 24 | 3 | GO:0043539 | |
| GeneOntologyMolecularFunction | protein kinase activator activity | 7.35e-04 | 149 | 24 | 3 | GO:0030295 | |
| GeneOntologyMolecularFunction | kinase activator activity | 8.87e-04 | 159 | 24 | 3 | GO:0019209 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein conjugating enzyme binding | 1.16e-03 | 42 | 24 | 2 | GO:0044390 | |
| GeneOntologyMolecularFunction | protein kinase regulator activity | 3.57e-03 | 259 | 24 | 3 | GO:0019887 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | 5.62e-03 | 1418 | 24 | 6 | GO:0030234 | |
| GeneOntologyMolecularFunction | kinase regulator activity | 5.63e-03 | 305 | 24 | 3 | GO:0019207 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 5.89e-03 | 310 | 24 | 3 | GO:0030246 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell degranulation | 4.84e-09 | 4 | 23 | 3 | GO:0043322 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell degranulation | 6.76e-08 | 8 | 23 | 3 | GO:0043321 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell activation | 5.46e-07 | 15 | 23 | 3 | GO:0032815 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell proliferation | 5.46e-07 | 15 | 23 | 3 | GO:2000562 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte degranulation | 8.15e-07 | 17 | 23 | 3 | GO:0043301 | |
| GeneOntologyBiologicalProcess | natural killer cell degranulation | 9.78e-07 | 18 | 23 | 3 | GO:0043320 | |
| GeneOntologyBiologicalProcess | negative regulation of alpha-beta T cell proliferation | 1.16e-06 | 19 | 23 | 3 | GO:0046642 | |
| GeneOntologyBiologicalProcess | positive regulation of defense response to bacterium | 1.16e-06 | 19 | 23 | 3 | GO:1900426 | |
| GeneOntologyBiologicalProcess | regulation of T cell chemotaxis | 1.36e-06 | 20 | 23 | 3 | GO:0010819 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell differentiation | 1.59e-06 | 21 | 23 | 3 | GO:0032823 | |
| GeneOntologyBiologicalProcess | regulation of defense response to bacterium | 3.10e-06 | 26 | 23 | 3 | GO:1900424 | |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, alpha-beta T cell proliferation | 3.90e-06 | 28 | 23 | 3 | GO:2000561 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell proliferation | 4.82e-06 | 30 | 23 | 3 | GO:0035739 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte chemotaxis | 5.33e-06 | 31 | 23 | 3 | GO:1901623 | |
| GeneOntologyBiologicalProcess | positive regulation of regulatory T cell differentiation | 5.33e-06 | 31 | 23 | 3 | GO:0045591 | |
| GeneOntologyBiologicalProcess | negative regulation of regulated secretory pathway | 5.88e-06 | 32 | 23 | 3 | GO:1903306 | |
| GeneOntologyBiologicalProcess | T cell chemotaxis | 6.47e-06 | 33 | 23 | 3 | GO:0010818 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation in thymus | 9.18e-06 | 37 | 23 | 3 | GO:0033081 | |
| GeneOntologyBiologicalProcess | natural killer cell differentiation | 9.96e-06 | 38 | 23 | 3 | GO:0001779 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.16e-05 | 40 | 23 | 3 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell activation | 1.16e-05 | 40 | 23 | 3 | GO:2000515 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell migration | 1.26e-05 | 41 | 23 | 3 | GO:2000406 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 1.26e-05 | 41 | 23 | 3 | GO:0002716 | |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 1.35e-05 | 42 | 23 | 3 | GO:0002323 | |
| GeneOntologyBiologicalProcess | positive regulation of macrophage activation | 1.35e-05 | 42 | 23 | 3 | GO:0043032 | |
| GeneOntologyBiologicalProcess | positive regulation of SMAD protein signal transduction | 1.45e-05 | 43 | 23 | 3 | GO:0060391 | |
| GeneOntologyBiologicalProcess | negative regulation of exocytosis | 1.67e-05 | 45 | 23 | 3 | GO:0045920 | |
| GeneOntologyBiologicalProcess | positive regulation of oxidoreductase activity | 1.78e-05 | 46 | 23 | 3 | GO:0051353 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 1.82e-05 | 144 | 23 | 4 | GO:0045582 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 1.90e-05 | 47 | 23 | 3 | GO:0001911 | |
| GeneOntologyBiologicalProcess | regulation of T-helper 17 type immune response | 1.90e-05 | 47 | 23 | 3 | GO:2000316 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-10 production | 2.03e-05 | 48 | 23 | 3 | GO:0032733 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte migration | 2.16e-05 | 49 | 23 | 3 | GO:2000403 | |
| GeneOntologyBiologicalProcess | regulation of regulatory T cell differentiation | 2.16e-05 | 49 | 23 | 3 | GO:0045589 | |
| GeneOntologyBiologicalProcess | negative regulation of type II interferon production | 2.44e-05 | 51 | 23 | 3 | GO:0032689 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 2.58e-05 | 52 | 23 | 3 | GO:0031342 | |
| GeneOntologyBiologicalProcess | negative regulation of alpha-beta T cell activation | 2.58e-05 | 52 | 23 | 3 | GO:0046636 | |
| GeneOntologyBiologicalProcess | lymphocyte chemotaxis | 2.74e-05 | 53 | 23 | 3 | GO:0048247 | |
| GeneOntologyBiologicalProcess | regulation of alpha-beta T cell proliferation | 2.74e-05 | 53 | 23 | 3 | GO:0046640 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 2.89e-05 | 162 | 23 | 4 | GO:0045621 | |
| GeneOntologyBiologicalProcess | regulatory T cell differentiation | 2.89e-05 | 54 | 23 | 3 | GO:0045066 | |
| GeneOntologyBiologicalProcess | regulation of T cell migration | 3.23e-05 | 56 | 23 | 3 | GO:2000404 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell proliferation | 3.78e-05 | 59 | 23 | 3 | GO:0046633 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell activation | 4.18e-05 | 61 | 23 | 3 | GO:0032814 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte degranulation | 4.60e-05 | 63 | 23 | 3 | GO:0043300 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 4.60e-05 | 63 | 23 | 3 | GO:0007157 | |
| GeneOntologyBiologicalProcess | T-helper 17 type immune response | 4.83e-05 | 64 | 23 | 3 | GO:0072538 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | 4.97e-05 | 375 | 23 | 5 | GO:0007162 | |
| GeneOntologyBiologicalProcess | regulation of vesicle-mediated transport | 7.05e-05 | 667 | 23 | 6 | GO:0060627 | |
| GeneOntologyBiologicalProcess | regulation of interleukin-10 production | 7.46e-05 | 74 | 23 | 3 | GO:0032653 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 8.07e-05 | 76 | 23 | 3 | GO:0042269 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte migration | 8.40e-05 | 77 | 23 | 3 | GO:2000401 | |
| GeneOntologyBiologicalProcess | interleukin-10 production | 8.40e-05 | 77 | 23 | 3 | GO:0032613 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 9.41e-05 | 80 | 23 | 3 | GO:0002715 | |
| GeneOntologyBiologicalProcess | T cell migration | 9.76e-05 | 81 | 23 | 3 | GO:0072678 | |
| GeneOntologyBiologicalProcess | regulation of macrophage activation | 9.76e-05 | 81 | 23 | 3 | GO:0043030 | |
| GeneOntologyBiologicalProcess | receptor clustering | 1.05e-04 | 83 | 23 | 3 | GO:0043113 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 1.05e-04 | 83 | 23 | 3 | GO:0002707 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 1.06e-04 | 226 | 23 | 4 | GO:0045580 | |
| GeneOntologyBiologicalProcess | positive regulation of chemokine production | 1.09e-04 | 84 | 23 | 3 | GO:0032722 | |
| GeneOntologyBiologicalProcess | regulation of oxidoreductase activity | 1.09e-04 | 84 | 23 | 3 | GO:0051341 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-1 production | 1.25e-04 | 88 | 23 | 3 | GO:0032732 | |
| GeneOntologyBiologicalProcess | regulation of SMAD protein signal transduction | 1.34e-04 | 90 | 23 | 3 | GO:0060390 | |
| GeneOntologyBiologicalProcess | cellular response to virus | 1.34e-04 | 90 | 23 | 3 | GO:0098586 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 1.37e-04 | 242 | 23 | 4 | GO:1902107 | |
| GeneOntologyBiologicalProcess | regulation of chemotaxis | 1.37e-04 | 242 | 23 | 4 | GO:0050920 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 1.37e-04 | 242 | 23 | 4 | GO:1903708 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-cell adhesion | 1.60e-04 | 252 | 23 | 4 | GO:0022408 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 1.62e-04 | 96 | 23 | 3 | GO:0002704 | |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, alpha-beta T cell activation | 1.82e-04 | 100 | 23 | 3 | GO:2000514 | |
| GeneOntologyBiologicalProcess | negative regulation of cell activation | 1.92e-04 | 264 | 23 | 4 | GO:0050866 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 1.97e-04 | 266 | 23 | 4 | GO:0045619 | |
| GeneOntologyBiologicalProcess | positive regulation of mononuclear cell migration | 2.05e-04 | 104 | 23 | 3 | GO:0071677 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 2.11e-04 | 105 | 23 | 3 | GO:0042267 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | 2.23e-04 | 107 | 23 | 3 | GO:0042130 | |
| GeneOntologyBiologicalProcess | leukocyte degranulation | 2.29e-04 | 108 | 23 | 3 | GO:0043299 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immunity | 2.35e-04 | 109 | 23 | 3 | GO:0002228 | |
| GeneOntologyBiologicalProcess | SMAD protein signal transduction | 2.42e-04 | 110 | 23 | 3 | GO:0060395 | |
| GeneOntologyBiologicalProcess | maintenance of protein location | 2.55e-04 | 112 | 23 | 3 | GO:0045185 | |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 2.69e-04 | 114 | 23 | 3 | GO:0045824 | |
| GeneOntologyBiologicalProcess | T cell differentiation in thymus | 2.69e-04 | 114 | 23 | 3 | GO:0033077 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell activation | 2.74e-04 | 290 | 23 | 4 | GO:0050870 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2.76e-04 | 115 | 23 | 3 | GO:0090100 | |
| GeneOntologyBiologicalProcess | lymphocyte migration | 2.83e-04 | 116 | 23 | 3 | GO:0072676 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-6 production | 3.28e-04 | 122 | 23 | 3 | GO:0032755 | |
| GeneOntologyBiologicalProcess | natural killer cell activation | 3.44e-04 | 124 | 23 | 3 | GO:0030101 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte proliferation | 3.44e-04 | 124 | 23 | 3 | GO:0050672 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 3.44e-04 | 124 | 23 | 3 | GO:0001910 | |
| GeneOntologyBiologicalProcess | regulation of chemokine production | 3.52e-04 | 125 | 23 | 3 | GO:0032642 | |
| GeneOntologyBiologicalProcess | negative regulation of mononuclear cell proliferation | 3.60e-04 | 126 | 23 | 3 | GO:0032945 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 3.67e-04 | 313 | 23 | 4 | GO:0098742 | |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | 3.79e-04 | 579 | 23 | 5 | GO:0045785 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | 3.82e-04 | 580 | 23 | 5 | GO:0022407 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte cell-cell adhesion | 3.85e-04 | 317 | 23 | 4 | GO:1903039 | |
| GeneOntologyBiologicalProcess | negative regulation of transport | 4.04e-04 | 587 | 23 | 5 | GO:0051051 | |
| GeneOntologyBiologicalProcess | positive regulation of tumor necrosis factor production | 4.22e-04 | 133 | 23 | 3 | GO:0032760 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | 4.24e-04 | 927 | 23 | 6 | GO:0030155 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte proliferation | 4.32e-04 | 134 | 23 | 3 | GO:0070664 | |
| GeneOntologyBiologicalProcess | chemokine production | 4.41e-04 | 135 | 23 | 3 | GO:0032602 | |
| GeneOntologyBiologicalProcess | positive regulation of tumor necrosis factor superfamily cytokine production | 4.61e-04 | 137 | 23 | 3 | GO:1903557 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 2.93e-04 | 530 | 24 | 5 | GO:0062023 | |
| GeneOntologyCellularComponent | extracellular matrix | 7.76e-04 | 656 | 24 | 5 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 7.87e-04 | 658 | 24 | 5 | GO:0030312 | |
| MousePheno | enhanced humoral immune response | 2.27e-06 | 17 | 22 | 3 | MP:0020155 | |
| MousePheno | increased T-helper 1 cell number | 3.23e-06 | 19 | 22 | 3 | MP:0008086 | |
| MousePheno | increased spleen germinal center size | 5.87e-06 | 23 | 22 | 3 | MP:0008483 | |
| MousePheno | abnormal lymph node germinal center morphology | 5.87e-06 | 23 | 22 | 3 | MP:0008522 | |
| MousePheno | abnormal T-helper 1 cell number | 6.70e-06 | 24 | 22 | 3 | MP:0008085 | |
| MousePheno | abnormal lymph node secondary follicle morphology | 7.61e-06 | 25 | 22 | 3 | MP:0002346 | |
| MousePheno | lymph node hyperplasia | 1.79e-05 | 33 | 22 | 3 | MP:0008102 | |
| MousePheno | thymus hyperplasia | 1.96e-05 | 34 | 22 | 3 | MP:0000708 | |
| MousePheno | increased susceptibility to induced arthritis | 2.34e-05 | 36 | 22 | 3 | MP:0003724 | |
| MousePheno | abnormal lymph node B cell domain morphology | 4.30e-05 | 44 | 22 | 3 | MP:0002344 | |
| MousePheno | abnormal T-helper 1 cell morphology | 5.59e-05 | 48 | 22 | 3 | MP:0002433 | |
| MousePheno | abnormal lymph node cortex morphology | 6.32e-05 | 50 | 22 | 3 | MP:0002343 | |
| MousePheno | increased T-helper cell number | 8.88e-05 | 56 | 22 | 3 | MP:0013763 | |
| MousePheno | decreased regulatory T cell number | 1.32e-04 | 64 | 22 | 3 | MP:0004974 | |
| MousePheno | increased B cell proliferation | 2.12e-04 | 75 | 22 | 3 | MP:0005154 | |
| MousePheno | abnormal Peyer's patch morphology | 2.87e-04 | 83 | 22 | 3 | MP:0000696 | |
| MousePheno | abnormal blood vessel physiology | 3.07e-04 | 394 | 22 | 5 | MP:0000249 | |
| MousePheno | abnormal gut-associated lymphoid tissue morphology | 3.07e-04 | 85 | 22 | 3 | MP:0002378 | |
| MousePheno | spleen hyperplasia | 3.07e-04 | 85 | 22 | 3 | MP:0000693 | |
| MousePheno | abnormal vasculature physiology | 3.45e-04 | 404 | 22 | 5 | MP:0031170 | |
| MousePheno | abnormal CD4-positive helper T cell morphology | 4.96e-04 | 100 | 22 | 3 | MP:0010183 | |
| MousePheno | abnormal spleen germinal center morphology | 6.04e-04 | 107 | 22 | 3 | MP:0002359 | |
| MousePheno | autoimmune arthritis | 6.21e-04 | 108 | 22 | 3 | MP:0002993 | |
| MousePheno | abnormal spleen secondary B follicle morphology | 6.38e-04 | 109 | 22 | 3 | MP:0008472 | |
| MousePheno | abnormal T-helper cell number | 7.27e-04 | 114 | 22 | 3 | MP:0013761 | |
| MousePheno | abnormal regulatory T cell number | 7.45e-04 | 115 | 22 | 3 | MP:0004972 | |
| MousePheno | abnormal regulatory T cell morphology | 7.84e-04 | 117 | 22 | 3 | MP:0004941 | |
| MousePheno | enlarged thymus | 1.01e-03 | 292 | 22 | 4 | MP:0000709 | |
| MousePheno | joint inflammation | 1.09e-03 | 131 | 22 | 3 | MP:0002933 | |
| MousePheno | abnormal vascular smooth muscle physiology | 1.32e-03 | 140 | 22 | 3 | MP:0005595 | |
| MousePheno | abnormal spleen B cell follicle morphology | 1.43e-03 | 144 | 22 | 3 | MP:0008470 | |
| MousePheno | abnormal joint physiology | 1.46e-03 | 145 | 22 | 3 | MP:0031169 | |
| MousePheno | abnormal T-helper cell morphology | 1.58e-03 | 149 | 22 | 3 | MP:0013760 | |
| MousePheno | abnormal B cell proliferation | 1.67e-03 | 152 | 22 | 3 | MP:0005153 | |
| MousePheno | abnormal auditory brainstem response | 1.72e-03 | 576 | 22 | 5 | MP:0004738 | |
| MousePheno | increased susceptibility to autoimmune disorder | 1.76e-03 | 155 | 22 | 3 | MP:0005350 | |
| MousePheno | abnormal hearing electrophysiology | 1.96e-03 | 594 | 22 | 5 | MP:0006335 | |
| MousePheno | abnormal B cell activation | 2.15e-03 | 166 | 22 | 3 | MP:0008217 | |
| MousePheno | increased vascular permeability | 2.35e-03 | 46 | 22 | 2 | MP:0003070 | |
| Domain | Gal-bind_lectin | 8.40e-07 | 15 | 24 | 3 | SM00908 | |
| Domain | GALECTIN | 8.40e-07 | 15 | 24 | 3 | PS51304 | |
| Domain | Galectin_CRD | 8.40e-07 | 15 | 24 | 3 | IPR001079 | |
| Domain | Gal-bind_lectin | 8.40e-07 | 15 | 24 | 3 | PF00337 | |
| Domain | GLECT | 8.40e-07 | 15 | 24 | 3 | SM00276 | |
| Domain | - | 2.39e-04 | 95 | 24 | 3 | 2.60.120.200 | |
| Domain | ConA-like_dom | 2.68e-03 | 219 | 24 | 3 | IPR013320 | |
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 16990264 | ||
| Pubmed | Galectin-9 Is Critical for Mucosal Adaptive Immunity through the T Helper 17-IgA Axis. | 2.89e-10 | 3 | 24 | 3 | 29458010 | |
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 18005988 | ||
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 23585851 | ||
| Pubmed | Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases. | 2.89e-10 | 3 | 24 | 3 | 31969388 | |
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 23836896 | ||
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 18282810 | ||
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 24477688 | ||
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 19776007 | ||
| Pubmed | A unique role for galectin-9 in angiogenesis and inflammatory arthritis. | 2.89e-10 | 3 | 24 | 3 | 29433546 | |
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 26582205 | ||
| Pubmed | Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia. | 2.89e-10 | 3 | 24 | 3 | 35241678 | |
| Pubmed | Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes. | 2.89e-10 | 3 | 24 | 3 | 7890611 | |
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 37105392 | ||
| Pubmed | Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner. | 2.89e-10 | 3 | 24 | 3 | 22341088 | |
| Pubmed | Regulation of M1‑type and M2‑type macrophage polarization in RAW264.7 cells by Galectin‑9. | 2.89e-10 | 3 | 24 | 3 | 28990062 | |
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 32380082 | ||
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 24083426 | ||
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 23667648 | ||
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 9153289 | ||
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 33316546 | ||
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 37279535 | ||
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 18974023 | ||
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 18579572 | ||
| Pubmed | The protective function of galectin-9 in liver ischemia and reperfusion injury in mice. | 2.89e-10 | 3 | 24 | 3 | 25931247 | |
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 9038233 | ||
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 22627368 | ||
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 28877989 | ||
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 33153471 | ||
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 19800850 | ||
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 22052881 | ||
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 17560833 | ||
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 23144904 | ||
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 38987795 | ||
| Pubmed | Impaired Gal-9 Dysregulates the PBMC-Induced Th1/Th2 Imbalance in Abortion-Prone Matings. | 2.89e-10 | 3 | 24 | 3 | 29651447 | |
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 36479526 | ||
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 28704475 | ||
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 21146220 | ||
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 23242525 | ||
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 35643073 | ||
| Pubmed | Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice. | 2.89e-10 | 3 | 24 | 3 | 19851072 | |
| Pubmed | The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes. | 2.89e-10 | 3 | 24 | 3 | 33923930 | |
| Pubmed | Galectin-9 functionally impairs natural killer cells in humans and mice. | 2.89e-10 | 3 | 24 | 3 | 23408620 | |
| Pubmed | Alarmin function of galectin-9 in murine respiratory tularemia. | 2.89e-10 | 3 | 24 | 3 | 25898318 | |
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 31937306 | ||
| Pubmed | 2.89e-10 | 3 | 24 | 3 | 21426359 | ||
| Pubmed | Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies. | 1.15e-09 | 4 | 24 | 3 | 24958847 | |
| Pubmed | 1.15e-09 | 4 | 24 | 3 | 19017954 | ||
| Pubmed | Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. | 1.15e-09 | 4 | 24 | 3 | 20463811 | |
| Pubmed | 1.15e-09 | 4 | 24 | 3 | 38686388 | ||
| Pubmed | 1.15e-09 | 4 | 24 | 3 | 30120235 | ||
| Pubmed | 1.15e-09 | 4 | 24 | 3 | 22677125 | ||
| Pubmed | 1.15e-09 | 4 | 24 | 3 | 32855403 | ||
| Pubmed | Galectin-3 mediates oligomerization of secreted hensin using its carbohydrate-recognition domain. | 1.15e-09 | 4 | 24 | 3 | 23657851 | |
| Pubmed | 1.15e-09 | 4 | 24 | 3 | 19234217 | ||
| Pubmed | Galectin-9 Targets NLRP3 for Autophagic Degradation to Limit Inflammation. | 1.15e-09 | 4 | 24 | 3 | 33963043 | |
| Pubmed | Galectin-9: A novel promoter of atherosclerosis progression. | 1.15e-09 | 4 | 24 | 3 | 36459823 | |
| Pubmed | [Expression of Galectin-9 and Tim-3 in lungs of mice with asthma]. | 1.15e-09 | 4 | 24 | 3 | 21575348 | |
| Pubmed | Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts. | 1.15e-09 | 4 | 24 | 3 | 18346632 | |
| Pubmed | 1.15e-09 | 4 | 24 | 3 | 11839756 | ||
| Pubmed | 1.15e-09 | 4 | 24 | 3 | 33107565 | ||
| Pubmed | 1.15e-09 | 4 | 24 | 3 | 19670381 | ||
| Pubmed | 1.15e-09 | 4 | 24 | 3 | 18826117 | ||
| Pubmed | Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models. | 1.15e-09 | 4 | 24 | 3 | 29611821 | |
| Pubmed | 1.15e-09 | 4 | 24 | 3 | 24333756 | ||
| Pubmed | 1.15e-09 | 4 | 24 | 3 | 30763585 | ||
| Pubmed | 1.15e-09 | 4 | 24 | 3 | 25450716 | ||
| Pubmed | The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. | 1.15e-09 | 4 | 24 | 3 | 16286920 | |
| Pubmed | 1.15e-09 | 4 | 24 | 3 | 38853593 | ||
| Pubmed | Galectin-9 regulates the threshold of B cell activation and autoimmunity. | 1.15e-09 | 4 | 24 | 3 | 34369876 | |
| Pubmed | Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2. | 1.15e-09 | 4 | 24 | 3 | 33727589 | |
| Pubmed | Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells. | 1.15e-09 | 4 | 24 | 3 | 19362679 | |
| Pubmed | 1.15e-09 | 4 | 24 | 3 | 33203936 | ||
| Pubmed | 1.15e-09 | 4 | 24 | 3 | 25578313 | ||
| Pubmed | 1.15e-09 | 4 | 24 | 3 | 29844236 | ||
| Pubmed | Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency. | 1.15e-09 | 4 | 24 | 3 | 22021615 | |
| Pubmed | 1.15e-09 | 4 | 24 | 3 | 35715604 | ||
| Pubmed | Embryonic implantation in galectin 1/galectin 3 double mutant mice. | 2.88e-09 | 5 | 24 | 3 | 9566950 | |
| Pubmed | 2.88e-09 | 5 | 24 | 3 | 29242193 | ||
| Pubmed | 2.88e-09 | 5 | 24 | 3 | 22469568 | ||
| Pubmed | 2.88e-09 | 5 | 24 | 3 | 37352334 | ||
| Pubmed | 2.88e-09 | 5 | 24 | 3 | 28951537 | ||
| Pubmed | 2.88e-09 | 5 | 24 | 3 | 33664349 | ||
| Pubmed | 2.88e-09 | 5 | 24 | 3 | 26278059 | ||
| Pubmed | The glucose transporter 2 regulates CD8+ T cell function via environment sensing. | 2.88e-09 | 5 | 24 | 3 | 37884694 | |
| Pubmed | 2.88e-09 | 5 | 24 | 3 | 25158758 | ||
| Pubmed | 2.88e-09 | 5 | 24 | 3 | 21385853 | ||
| Pubmed | Galectin-9 mediates neutrophil capture and adhesion in a CD44 and β2 integrin-dependent manner. | 2.88e-09 | 5 | 24 | 3 | 34847625 | |
| Pubmed | C/EBPzeta (CHOP/Gadd153) is a negative regulator of LPS-induced IL-6 expression in B cells. | 2.88e-09 | 5 | 24 | 3 | 19782405 | |
| Pubmed | 5.77e-09 | 6 | 24 | 3 | 8674632 | ||
| Pubmed | Tim3 binding to galectin-9 stimulates antimicrobial immunity. | 5.77e-09 | 6 | 24 | 3 | 20937702 | |
| Pubmed | 5.77e-09 | 6 | 24 | 3 | 28394331 | ||
| Pubmed | 5.77e-09 | 6 | 24 | 3 | 23296703 | ||
| Pubmed | Role of galectin-1 in the developing mouse olfactory system. | 1.01e-08 | 7 | 24 | 3 | 8873770 | |
| Pubmed | 1.61e-08 | 8 | 24 | 3 | 31661141 | ||
| Pubmed | 1.61e-08 | 8 | 24 | 3 | 23751344 | ||
| Pubmed | 1.61e-08 | 8 | 24 | 3 | 36883358 | ||
| Pubmed | 2.42e-08 | 9 | 24 | 3 | 21670307 | ||
| Pubmed | Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells. | 2.42e-08 | 9 | 24 | 3 | 25065622 | |
| Pubmed | 6.33e-08 | 12 | 24 | 3 | 23817958 | ||
| Interaction | RRAGB interactions | 4.70e-07 | 54 | 24 | 4 | int:RRAGB | |
| Interaction | FUBP3 interactions | 2.27e-05 | 297 | 24 | 5 | int:FUBP3 | |
| Interaction | ABCC4 interactions | 3.95e-05 | 56 | 24 | 3 | int:ABCC4 | |
| Interaction | RRAGC interactions | 9.47e-05 | 75 | 24 | 3 | int:RRAGC | |
| Interaction | CD47 interactions | 1.11e-04 | 79 | 24 | 3 | int:CD47 | |
| GeneFamily | Galectins | 2.09e-07 | 15 | 15 | 3 | 629 | |
| Coexpression | UEDA_PERIFERAL_CLOCK | 1.92e-05 | 177 | 24 | 4 | MM1145 | |
| Coexpression | P53_DN.V1_UP | 2.75e-05 | 194 | 24 | 4 | M2698 | |
| Coexpression | MORI_MATURE_B_LYMPHOCYTE_DN | 5.91e-05 | 83 | 24 | 3 | MM596 | |
| Coexpression | BURTON_ADIPOGENESIS_9 | 7.27e-05 | 89 | 24 | 3 | MM1026 | |
| Coexpression | MORI_LARGE_PRE_BII_LYMPHOCYTE_UP | 8.29e-05 | 93 | 24 | 3 | MM1137 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_UP | 1.03e-04 | 100 | 24 | 3 | MM514 | |
| Coexpression | MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP | 1.56e-04 | 115 | 24 | 3 | MM599 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_BASAL_CELL_AGEING | 1.96e-04 | 322 | 24 | 4 | MM3786 | |
| Coexpression | TABULA_MURIS_SENIS_SKIN_EPIDERMAL_CELL_AGEING | 2.10e-04 | 618 | 24 | 5 | MM3829 | |
| Coexpression | OSADA_ASCL1_TARGETS_DN | 2.19e-04 | 24 | 24 | 2 | M4336 | |
| Coexpression | MARKEY_RB1_CHRONIC_LOF_DN | 2.24e-04 | 130 | 24 | 3 | MM975 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | 2.60e-04 | 647 | 24 | 5 | MM981 | |
| Coexpression | MIKKELSEN_MEF_LCP_WITH_H3K4ME3 | 2.90e-04 | 142 | 24 | 3 | MM840 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 3.14e-04 | 146 | 24 | 3 | MM973 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D | 3.16e-04 | 675 | 24 | 5 | MM1073 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | 3.89e-04 | 1106 | 24 | 6 | M39071 | |
| Coexpression | NABA_ECM_AFFILIATED | 3.96e-04 | 158 | 24 | 3 | MM17063 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN | 4.11e-04 | 160 | 24 | 3 | MM974 | |
| Coexpression | NABA_ECM_AFFILIATED | 4.91e-04 | 170 | 24 | 3 | M5880 | |
| Coexpression | MIKKELSEN_MCV6_LCP_WITH_H3K4ME3 | 5.25e-04 | 174 | 24 | 3 | MM836 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP | 6.58e-04 | 188 | 24 | 3 | MM983 | |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | 6.73e-04 | 1226 | 24 | 6 | MM979 | |
| Coexpression | GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_UP | 7.76e-04 | 199 | 24 | 3 | M9420 | |
| Coexpression | GSE40441_NRP1_POS_INDUCED_TREG_VS_NRP1_NEG_NATURAL_TREG_DN | 7.76e-04 | 199 | 24 | 3 | M9195 | |
| Coexpression | GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_UP | 7.87e-04 | 200 | 24 | 3 | M7294 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_DN | 7.87e-04 | 200 | 24 | 3 | M9411 | |
| Coexpression | GSE27859_CD11C_INT_F480_HI_MACROPHAGE_VS_CD11C_ING_F480_INT_DC_DN | 7.87e-04 | 200 | 24 | 3 | M8598 | |
| Coexpression | GSE43863_TH1_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN | 7.87e-04 | 200 | 24 | 3 | M9768 | |
| Coexpression | GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_UP | 7.87e-04 | 200 | 24 | 3 | M3275 | |
| Coexpression | GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP | 7.87e-04 | 200 | 24 | 3 | M6027 | |
| Coexpression | GSE360_L_DONOVANI_VS_T_GONDII_MAC_DN | 7.87e-04 | 200 | 24 | 3 | M5234 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_ASTROCYTE_AGEING | 8.42e-04 | 474 | 24 | 4 | MM3685 | |
| Coexpression | BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN | 8.83e-04 | 48 | 24 | 2 | M10253 | |
| Coexpression | BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN | 8.83e-04 | 48 | 24 | 2 | MM1088 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.37e-06 | 178 | 24 | 4 | d3a75a8082e70543b84c35d53fe77625300d19fa | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.37e-06 | 178 | 24 | 4 | b2cda1df801b1a1a41e3dd2808baef37765cd804 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.47e-06 | 180 | 24 | 4 | 8ba9bba0c9fecf184a4332ba4585fb2439f68cd3 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.58e-06 | 182 | 24 | 4 | e98ca9df33a1a81fc83ecf73d5141a14f2bc985c | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.61e-06 | 198 | 24 | 4 | efdbac7a3a02bff4ca48841772e0c136556c2b9b | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.61e-06 | 198 | 24 | 4 | a631be84e29c277216d89ec6265bd43e87c1dc86 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.94e-05 | 169 | 24 | 3 | f68195510b91e287fe1507455ca067ece77a3897 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 1.01e-04 | 170 | 24 | 3 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 1.05e-04 | 172 | 24 | 3 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-04 | 175 | 24 | 3 | 8727252bcbc70bfa2ff72e7421df9cfe6fd4eed7 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Neurosecretory|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-04 | 175 | 24 | 3 | 38dec78efc99fe23479cba68cfa441e62bd6a08b | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-Tuft-related|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-04 | 175 | 24 | 3 | c083abe368e5c0dc2b0f27f375c9271a2d7ff64f | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 1.18e-04 | 179 | 24 | 3 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.18e-04 | 179 | 24 | 3 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.20e-04 | 180 | 24 | 3 | 535a890bde0d978b461c2d4c571529b585c76b21 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_KLHL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.26e-04 | 183 | 24 | 3 | 439b1d1373b7cc73d65f3b59037a6def7cf8f4ba | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 1.30e-04 | 185 | 24 | 3 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 185 | 24 | 3 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 185 | 24 | 3 | efcfbf5a48b3ea9a425183e5c2eec6a9585415a0 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 185 | 24 | 3 | 642088ace9230d38b0579853c54ff4dd8b5d5df4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.32e-04 | 186 | 24 | 3 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.36e-04 | 188 | 24 | 3 | 5bc1537e079c7435196c163bff5f639ea392a33a | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 188 | 24 | 3 | 0aa8747c2931b0c91f6d78bb2db8fd8ede6dd559 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____podocyte-2|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 188 | 24 | 3 | c300accbac71a3bc075fe985543d8a8ead82531b | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.38e-04 | 189 | 24 | 3 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 190 | 24 | 3 | 25525fee1da8a808034d9c916159fd0b6b26bce8 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 190 | 24 | 3 | a08c5929b05a4969852e351a93c4e4deb4c8d5b6 | |
| ToppCell | MatrixFB-Fibroblast-D_(Pericyte)|MatrixFB / shred on cell class and cell subclass (v4) | 1.45e-04 | 192 | 24 | 3 | 630444302511f511ec6976bc045a3b4b9d8d4547 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 192 | 24 | 3 | 8b625c22dda23c99654c82c529a1233e99e71b54 | |
| ToppCell | 15-Airway-Mesenchymal-Pericyte|Airway / Age, Tissue, Lineage and Cell class | 1.49e-04 | 194 | 24 | 3 | 5c1218d239c88082496924653ed2a092dc44a906 | |
| ToppCell | EC-Arteriolar_ECs|World / Lineage and Cell class | 1.49e-04 | 194 | 24 | 3 | 38f0c52de252101d4bc8633af80002061635e487 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 1.49e-04 | 194 | 24 | 3 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.52e-04 | 195 | 24 | 3 | c5f33b420c9ac14dc67fea632b8c2bc2442cbf3d | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet-Goblet_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.52e-04 | 195 | 24 | 3 | 219c5d0cde7f6082755154f54db221413ec555cb | |
| ToppCell | distal-1-Epithelial-Basal|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.56e-04 | 197 | 24 | 3 | 25a2ccc98b973611de0d920b1b455d0b40f0d37f | |
| ToppCell | distal-Epithelial-Basal-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.56e-04 | 197 | 24 | 3 | 75b4292ce2ad7f9c8b6a4781e1cb71f5b18b74e3 | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.59e-04 | 198 | 24 | 3 | 1eb49b853a9e144e840c660060473fc7873f6478 | |
| ToppCell | (04)_Interm._basal>secr.|World / shred by cell type by condition | 1.61e-04 | 199 | 24 | 3 | ed399244433f781fc291a9bff16825b8a3ca294f | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Late_airway_progenitor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.61e-04 | 199 | 24 | 3 | 494461665f945ce6c97299c58f7785e90dec5812 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.56e-04 | 65 | 24 | 2 | 8f7eac868f1605830cc97d9d1676f3ebff47d49b | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)--|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.56e-04 | 65 | 24 | 2 | 350f33bcc5924d7e3c3318391d33a984763fe206 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.56e-04 | 65 | 24 | 2 | c736a773a1b9cb16b51849a3bf0ccd9aeec7b342 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Tgfb2_(Tgfb2)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 9.26e-04 | 84 | 24 | 2 | 43e77117579290446a7e386c0be3459d652d9384 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gm9946_(Gm9946)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.26e-04 | 84 | 24 | 2 | 7da70a68b28fc0414ac3ac7dcd6f6edb56a5e76d | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Tgfb2_(Tgfb2)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 9.26e-04 | 84 | 24 | 2 | 38a457a20701fe23c6326b7282cd0993cdd87082 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Tgfb2_(Tgfb2)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 9.26e-04 | 84 | 24 | 2 | 59d0415bb6b6b18a94d2c9c6289fa9cbcb2166e3 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gm9946_(Gm9946)--|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.26e-04 | 84 | 24 | 2 | 3804a8a4d371eb104da4cde23c2db3df942b44de | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gm9946_(Gm9946)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.26e-04 | 84 | 24 | 2 | e865b8507c27f226eb69ee6c051516f347f79712 | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Blood_Derived_Cancer_-_Peripheral_Blood-Leukemia-Acute_Myeloid_Leukemia-2|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 1.26e-03 | 98 | 24 | 2 | 2407ffa8d3ccd108bb71095a75add672279a6a58 | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.28e-03 | 99 | 24 | 2 | 0d5684978f34258d4eb4941eb6c60393a9bc84ed | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.28e-03 | 99 | 24 | 2 | 1244f50bb66eea555a284ff5c35ac755d1e9080d | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.28e-03 | 99 | 24 | 2 | 0c27df8ecc1956b056930da9ab1c96df7fb9f7b5 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.49e-03 | 107 | 24 | 2 | fc07dd90f280191bd643398eac5c8273651d0925 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.55e-03 | 109 | 24 | 2 | 4e4a884b8979f4ff8b232c1581ea78884dda29ed | |
| ToppCell | RA-04._Ventricular_Cardiomyocyte_I|RA / Chamber and Cluster_Paper | 1.58e-03 | 110 | 24 | 2 | af7095c6e1501a4440be39b5c16d4872dd6d66e5 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Cbln4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.72e-03 | 115 | 24 | 2 | ac73aa06e617ed791c6ae9e38189bac74188c27b | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Cdkn2b_(Cdkn2b)--|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.84e-03 | 119 | 24 | 2 | 8a3f0a3ed9f80d7b061162e9fa519bb09804a86c | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.84e-03 | 119 | 24 | 2 | e868453c02dcf0e07821886b81ca739887d43c67 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Cdkn2b_(Cdkn2b)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.84e-03 | 119 | 24 | 2 | 938da0fe90372709048bf4e5503cc1cbf8376b17 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Cdkn2b_(Cdkn2b)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.84e-03 | 119 | 24 | 2 | a3807e738d7ca8cf80aa4bd35e3ee4357b1dc00f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Tmem182|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.00e-03 | 124 | 24 | 2 | 690595d710b57b7cff8029a3bb06a8dd7e3c03c1 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.03e-03 | 125 | 24 | 2 | d05556ea185c15815a4f8643f1c01185badbeece | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Necab1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.06e-03 | 126 | 24 | 2 | 28fbe63f7bc628b32d8e86bf9e80657e776dd1cc | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Cbln4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.06e-03 | 126 | 24 | 2 | 94bd9cfe982b41a3114885173eab55feb0fbbbae | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Necab1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.06e-03 | 126 | 24 | 2 | a4fc7ac4931d2fc8aa8196a62d809b698937aa9c | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue-6|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.09e-03 | 127 | 24 | 2 | d61b71572eab8a850ee8ce54323fb247525006e5 | |
| ToppCell | primary_visual_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Cytl1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.09e-03 | 127 | 24 | 2 | eee8e4a83f7de46807440d202d46eee7dd722001 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.16e-03 | 129 | 24 | 2 | f83187c0bb06528127b8d2d56674ab1946846951 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crh_4930553C11Rik_|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.16e-03 | 129 | 24 | 2 | 6bc85761dea1f97c19bb379a99e4daf85d53201e | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Tmem182|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.19e-03 | 130 | 24 | 2 | 8bd038b0423960ffdc6c8b128c46a55386f9c58c | |
| ToppCell | BAL-Severe-cDC_6|Severe / Compartment, Disease Groups and Clusters | 2.19e-03 | 130 | 24 | 2 | 4104d1e10609331b67db3b85c63537aec58b1713 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.23e-03 | 131 | 24 | 2 | d46bb28612b9690b2e3550b8adbd10781788c00d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Eya1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.33e-03 | 134 | 24 | 2 | 657ad905b40ec3f82acdef824431b8276d291ef7 | |
| ToppCell | PBMC-Mild-cDC_2|Mild / Compartment, Disease Groups and Clusters | 2.36e-03 | 135 | 24 | 2 | cb9d834f8301cf53f20e09c3f4cb6a148690196a | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crhr2_Efemp1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.40e-03 | 136 | 24 | 2 | e3a2425ba5ef538dbacab1479e682837ae42a888 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-5|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.43e-03 | 137 | 24 | 2 | a7c76201b8901b2ef7ebbb4dfe0cec0dc4534ef5 | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_STALK|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.43e-03 | 137 | 24 | 2 | d37f425b13bc046baa1f8619b98a16b936f88ff6 | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.43e-03 | 137 | 24 | 2 | 306b11b3b9e5fd562d845fb5eaa4ac982864efce | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-03 | 138 | 24 | 2 | 321070b6900887b27da0f2b25808a05a8ab89ee7 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-03 | 138 | 24 | 2 | 19ffd66256fa94d728138d37d0a5a3bac7722dbb | |
| ToppCell | metastatic_Brain-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 2.47e-03 | 138 | 24 | 2 | b2ab273f3e62f169b3b9cb82342e6617af99f582 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac1_Htr1d|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.50e-03 | 139 | 24 | 2 | fe1657ef9aeda7c530dc7febcd3dcd0e1d5f8a48 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_STALK|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.64e-03 | 143 | 24 | 2 | 35d3652680c4dddd293301595d813161c66e5673 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.64e-03 | 143 | 24 | 2 | 24fd24846fbef049af669a57d42fcc18928d2b27 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.68e-03 | 144 | 24 | 2 | 1c118b22c2ff3a526a5207d6c9d772636ee065fd | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.68e-03 | 144 | 24 | 2 | 71107275767a0728541a3695715c44874b3e5efc | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_D2|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.72e-03 | 145 | 24 | 2 | 3a34c25ff77cd33fdca84742097cc7484066ebc4 | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 2.83e-03 | 148 | 24 | 2 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | E16.5-samps-Mesenchymal-Pericyte-pericyte_A|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.83e-03 | 148 | 24 | 2 | c87fe2373418ec0cfe37279003d1c4df4c0d0aac | |
| ToppCell | E16.5-samps-Mesenchymal-Pericyte|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.83e-03 | 148 | 24 | 2 | e697a7fb037873c9b11703d1bf836a69fc276e23 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.87e-03 | 149 | 24 | 2 | 9286bc56ff2e245630537a0bda5f1a1e17be863a | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.87e-03 | 149 | 24 | 2 | f53151d9e5e724a61be0ee6a8c740d1990f28d5f | |
| ToppCell | Club_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.87e-03 | 149 | 24 | 2 | 81c813588bb5efb7b31141a75d387210dcb76094 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_D2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.98e-03 | 152 | 24 | 2 | 595afcfa8b161e291fcaf2afc7336bac9b6fae0f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.98e-03 | 152 | 24 | 2 | 364c6016c38c6040c10e8ae4683096c4cdbe03fa | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-03 | 153 | 24 | 2 | a8f83ec640fae51d4fba34b92e3d6cca4999e930 | |
| ToppCell | IIH-CD4-CD4_Treg|IIH / Condition, Cell_class and T cell subcluster | 3.02e-03 | 153 | 24 | 2 | 28fb5d9f66f58741a5d43df004f80da3d910682e | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D2|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.02e-03 | 153 | 24 | 2 | 0b3b199678d4a70b0590393568c69454bece5c14 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac1_Htr1d|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.10e-03 | 155 | 24 | 2 | 79264ff283e36a059040a5aa9fe7337be694cb52 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Sema3c|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.10e-03 | 155 | 24 | 2 | 5c7b68b59244525e3714806c205a57a2daebf423 | |
| Disease | beta-aminoisobutyric acid measurement | 1.45e-04 | 24 | 22 | 2 | EFO_0010464 | |
| Disease | cognitive behavioural therapy | 8.55e-04 | 58 | 22 | 2 | EFO_0007820 | |
| Disease | hearing threshold measurement, hearing measurement | 9.46e-04 | 61 | 22 | 2 | EFO_0007616, EFO_0007618 | |
| Disease | serum dimethylarginine measurement | 1.01e-03 | 63 | 22 | 2 | EFO_0005418 | |
| Disease | serum IgE measurement | 1.04e-03 | 64 | 22 | 2 | EFO_0004579 | |
| Disease | gastroesophageal reflux disease | 2.56e-03 | 101 | 22 | 2 | EFO_0003948 | |
| Disease | lifestyle measurement, depressive symptom measurement | 2.77e-03 | 105 | 22 | 2 | EFO_0007006, EFO_0010724 | |
| Disease | QRS-T angle | 2.82e-03 | 106 | 22 | 2 | EFO_0020097 | |
| Disease | esterified cholesterol measurement | 4.07e-03 | 128 | 22 | 2 | EFO_0008589 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 4.65e-03 | 137 | 22 | 2 | EFO_0004611, EFO_0008591 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 4.78e-03 | 139 | 22 | 2 | DOID:3908 (is_implicated_in) | |
| Disease | age at onset, Myopia | 5.55e-03 | 150 | 22 | 2 | EFO_0004847, HP_0000545 | |
| Disease | colorectal cancer, colorectal adenoma | 5.69e-03 | 152 | 22 | 2 | EFO_0005406, MONDO_0005575 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PRMPPCDFMPERYQS | 46 | Q9BYV1 | |
| TYPMPQTPMGCPQPT | 2156 | O75179 | |
| MPFSVYGNAMIPPVA | 2531 | O75179 | |
| VNEGPVFYPDPMMVT | 471 | P55290 | |
| PCVPSRPDVMFMVYP | 166 | O95190 | |
| QMFSQTPAIPPMMYP | 206 | Q6DKI2 | |
| PVCFAPNMMYPVPVS | 961 | Q99700 | |
| QMFSQTPAIPPMMYP | 206 | Q3B8N2 | |
| QMFSTPAIPPMMYPH | 206 | O00182 | |
| MYTPKMPIAQPCNIF | 421 | Q8N6G6 | |
| LPQPPSPMPYASCQM | 206 | P58012 | |
| RMVYMPGDVPVCSPQ | 331 | Q9UHC3 | |
| YAWVPNAPCTMRMPP | 551 | P18054 | |
| TVVAIFPSPMMYAGP | 486 | O43252 | |
| PVAPMTPYLMLCQPH | 26 | Q6UW32 | |
| PMCPEMYVPEPTNIP | 871 | Q9NZV1 | |
| PQILMYAAPEPMGPC | 1946 | Q8IWT3 | |
| LMPAPCAQVMGFYHP | 111 | Q93073 | |
| MAAAPPSYCFVAFPP | 1 | Q12765 | |
| PYMAPCLPFVPAFAM | 626 | Q8TBB6 | |
| QVNMPYVMIPAFPPS | 221 | Q9UN79 | |
| PLPGVAMMQIVSCPY | 376 | O14776 | |
| LYCQKVPVPFSMPIP | 881 | Q14202 | |
| VPMTMCLFPVPFPLT | 66 | Q9P2D8 | |
| MPPCTYTMPSQFLPQ | 281 | Q13887 |